Dr. James Swartz is a Co-Founder of GreenLight Biosciences and a Professor in the Departments of Bioengineering and Chemical Engineering at Stanford University. Prof. Swartz has over twenty years of industrial experience at Eli Lilly and Genentech in the genetic engineering of recombinant organisms, and in the development of large scale processes for recombinant protein production. His research seeks to reproduce and direct complex metabolism in a cell-free environment. Prof Swartz is also a co-founder of Sutro Biopharma, Inc. and of Bullet Biotechnology. He also serves on the Board of Directors for Sutro Biopharma. He is a co-author or inventor for numerous scientific publications and patents related to large scale protein production as well as cell-free protein synthesis. Prof. Swartz holds a Master and Doctorate of Science degree in Chemical Engineering and Biochemical Engineering from the Massachusetts Institute of Technology, and a Bachelor of Science degree in Chemical Engineering from the South Dakota School of Mines.